The evolving landscape in advanced penile cancer

Future Sci OA. 2015 Nov 1;1(3):FSO9. doi: 10.4155/fso.15.7. eCollection 2015 Nov.

¹ Division of Medical Oncology, Centro di Riferimento Oncologico di Basilicata, I.R.C.C.S, Via Padre Pio 1, 85028 Rionero in Vulture, PZ, Italy; Division of Medical Oncology, Centro di Riferimento Oncologico di Basilicata, I.R.C.C.S, Via Padre Pio 1, 85028 Rionero in Vulture, PZ, Italy.
² Medical Oncology Unit, Department of Clinical Medicine, Federico II University, Naples, Italy; Medical Oncology Unit, Department of Clinical Medicine, Federico II University, Naples, Italy.
³ Divisione di Urologia, Istituto Europeo di Oncologia, Milano, Italy; Divisione di Urologia, Istituto Europeo di Oncologia, Milano, Italy.
⁴ Medical Oncology Department POC SS Annunziata Taranto, Italy; Medical Oncology Department POC SS Annunziata Taranto, Italy.
⁵ IOS SrL e Coleman SPA, Naples, Italy; IOS SrL e Coleman SPA, Naples, Italy.

No abstract available

Keywords: chemotherapy; immunotherapy; penile cancer; targeted therapy.

Publication types